Trials / Recruiting
RecruitingNCT06548256
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Detailed description
The physician will explain the trial procedures in the outpatient, and then obtain the written informed consent to start the interview. And randomly divided into experimental and observation groups, and according to the timing of taking Miyarisan, scale evaluation and sample collection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Miyarisan-BM (Clostridium Butyricum Miyairi) | probiotics |
Timeline
- Start date
- 2023-10-31
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-08-12
- Last updated
- 2024-08-12
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06548256. Inclusion in this directory is not an endorsement.